The 2013 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will bring 30 of the region’s most innovative private and public life science companies together to present to a targeted audience of biotech, device, diagnostic and pharma investors and strategic partners. The conference is being held September 18-19 at The Ritz-Carlton, Denver.

1. Rocky Mountain Life Science Investor & Partnering Conference Announces
Thirty Regional Companies for 2013 Presentation Lineup
The 2013 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will bring 30 of the
region’s most innovative private and public life science companies together to present to a targeted
audience of biotech, device, diagnostic and pharma investors and strategic partners. The conference is being
held September 18‐19 at The Ritz‐Carlton, Denver.
Denver, CO, August 19, 2013 (updated from August 12, 2013) – Thirty companies from Arizona, Colorado, Montana and
Utah have been chosen to present at the 2013 Rocky Mountain Life Science Investor and Partnering Conference
(RMLIPC), September 18‐19, at The Ritz‐Carlton in Denver, Colorado. The announcement is made by April Giles,
President & CEO of the Colorado BioScience Association (CBSA), on behalf of the RMLIPC Selection Committee, who says
the presenting companies were selected from more than 60 applicants by a committee of investors and industry
experts.
“Our investor and partnering conference, held every other year, is one of the most important events we orchestrate at
CBSA. It has been a rewarding experience for our team to see the conference grow and develop since our first session in
2009,” Giles said. “We owe our success to the support of our founding partner, Johnson & Johnson Development
Corporation, who has contributed significantly and been instrumental to the growth of this conference. We currently
have confirmation from just shy of 50 investors from across the country to participate in the conference.”
2013 Rocky Mountain Life Science Investor and Partnering Conference Presenting Companies:
AmideBio, LLC Boulder, CO http://www.amidebio.com
Biodesix Boulder, CO http://www.biodesix.com
BioFusionary Wheat Ridge, CO http://biofusionary.com
Boulder Diagnostics Boulder, CO http://www.boulderdiagnostics.com
Convoy Therapeutics Oro Valley, AZ http://www.convoytx.com
DiscGenics Salt Lake City, UT http://discgenics.com
EndoShape Boulder, CO http://endoshape.com
ENDURX Pharmaceuticals, Inc. Oro Valley, AZ http://www.endurxpharma.com
FitBionic Boulder, CO http://www.fitbionic.com
Lazarus Medical Technologies Salt Lake City, UT http://www.lazarusmedtech.com
Lineagen Salt Lake City, UT http://www.lineagen.com
MBio Diagnostics Boulder, CO http://mbiodx.com
MSDx Tucson, AZ http://www.msdx.co
Nasseo, Inc. Peoria, AZ http://www.nasseo.com
Neuro Assessment Systems Littleton, CO http://www.neuroassessments.com
Prima‐Temp, Inc Boulder, CO http://prima‐temp.com
Regenesis Biomedical Scottsdale, AZ http://www.regenesisbio.com
Renaptys Vaccines, LLC Aurora, CO http://www.renaptys.com
Rocky Mountain Biologicals Missoula, MT http://rmbio.com
Sharklet Technologies, Inc. Aurora, CO http://sharklet.com
‐More‐

2. Page 2
Sinopsys Surgical Boulder, CO http://www.sinopsyssurgical.com
Surefire Medical Westminster, CO http://surefiremedical.com
SuviCa Boulder, CO http://suvica.com
Transverse Medical Evergreen, CO http://www.transversemedical.com
Ventria Bioscience Fort Collins, CO http://ventria.com
VetDC Inc. Fort Collins, CO http://www.vet‐dc.com
Vivaldi Biosciences Fort Collins, CO http://www.vivaldibiosciences.com
Wasatch Salt Lake City, UT http://www.microfl.com
Xalud Therapeutics, Inc. Boulder, CO http://www.xaludthera.com
Xenograft Corporation Missoula, MT http://www.ihimontanafoundation.org
Note: as previously announced, Applied Microarrays Inc., Tempe, AZ http://www.appliedmicroarrays.com had to drop
out of the conference ‐‐ Xalud Therapeutics, Inc., Boulder, CO http://www.xaludthera.com has been added to the lineup.
About the Rocky Mountain Life Science Investor & Partnering Conference
The 2013 Rocky Mountain Life Science Investor & Partnering Conference – spearheaded by the Colorado BioScience
Association in collaboration with associations in Arizona, Montana, New Mexico and Utah — will open with a reception
at the Colorado Governor’s Mansion September 18th
and follow with a full day of company pitch presentations
September 19th
. The keynote breakfast will include Kyle Lefkoff, founder and General Partner of Boulder Ventures,
leading a conversation with the CEOs of Colorado's two premier publicly‐traded pharmaceutical companies‐Patrick
Mahaffy, Founder and CEO of Clovis Oncology and Ron Squarer, CEO of Array BioPharma. The keynote lunch will be a
presentation from Johnson & Johnson Development Corporation executive leadership. For more information and
registration details, visit http://www.RockyMtnBioInvest.com. On Twitter, please use the hashtag #RockyMtnBioInvest
for your tweets.
About Colorado BioScience Association
The CBSA is a not‐for‐profit organization providing services and support for Colorado's bioscience industry. With more
than 350 members, CBSA actively works to promote the growth of the industry by advocating for a better business
environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry in the
state, and speaking with a single voice on behalf of the industry. For more information, visit
http://www.cobioscience.com.
CBSA also is found on these social media sites:
Twitter: http://www.twitter.com/COBioscience
LinkedIn Group: http://www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro
Facebook Fan Page: http://www.facebook.com/ColoradoBioScienceAssociation
News Feed: http://coloradobio.blogspot.com
YouTube Channel: http://www.youtube.com/COBioscience
Pinterest: http://pinterest.com/COBioscience
Tumblr: http://cobioscience.tumblr.com
# # #
Contacts:
Mae Desaire, Director of Marketing, Colorado BioScience Association ‐ http://www.cobioscience.com – 720‐382‐5918,
mdesaire@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely PR – http://www.absolutelypr.com – 303‐984‐9801,
maggie@absolutelypr.com